MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2022 International Congress

September 15-18, 2022. Madrid, Spain.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Glial neurotrophic factor as an early diagnostic marker in Parkinson’s disease

    M. Matmurodov, A. Abduqodirov, L. Khalimova, B. Muminov (Tashkent, Uzbekistan)

  • Globus pallidus as a neurosurgical target in the management of levodopa-induced dyskinesias

    A. Simonyan, V. Tyurnikov, V. Poleshuk, A. Simonyan, A. Gushcha (Moscow, Russian Federation)

  • GLUT1 Deficiency Syndrome with Novel mutation responsive to GPi DBS

    C. Torres Vásquez, C. Zepeda Salazar, M. Rodriguez Violante, G. Cervantes Arriaga, D. Tristan, V. Cerino, T. Ortegano, A. Abundes Corona (Ciudad de mexico, Mexico)

  • GNAO1 related disorders: a clinical, genetic, and therapeutic update

    M. Novelli, S. Galosi, G. Zorzi, T. Granata, F. Nardecchia, M. Di Rocco, S. Martinelli, N. Nardocci, V. Leuzzi (Rome, Italy)

  • Goals for Improvement in Essential Tremor Patients Following Focused Ultrasound VIM Thalamotomy

    L. O'Brien, K. Lyons, V. Sharma, R. Pahwa (Kansas City, USA)

  • Gold and silver nanoparticle-based Localized Surface Plasmon Resonance Sensor (LSPR) for the detection of histidine as a potential biomarker in Parkinson’s Disease.

    E. Robles, C. Acevedo-Castillo, D. Martínez-Ramírez (Monterrey, Mexico)

  • GP2: Growing a research community in the Parkinson’s disease genetics field through training and networking

    S. Dey, A. Noyce, C. Bale, M. Kuhl, H. Leonard, P. Lewis, S. Stott, J. Callanan, A. Martinez-Carrasco, S. Bandres-Ciga, G. Genetics Program (London, United Kingdom)

  • GPi-DBS induced brain metabolic activation in cervical dystonia

    EA. Honkanen, J. Korpela, E. Pekkonen, J. Aaltonen, M. Koivu, O. Eskola, H. Eldebakey, J. Volkmann, V. Kaasinen, MM. Reich, J. Joutsa (Turku, Finland)

  • Gray matter volume of proposed brain-first and body-first Parkinson’s disease subtypes

    M. Banwinkler, V. Dzialas, M. Hoenig, T. van Eimeren (Cologne, Germany)

  • Gray matter volumetry, cortical thickness and cognitive performance in treated Parkinson’s disease with REM sleep behavior disorder symptomatology

    J. Oltra, A. Campabadal, C. Uribe, J. Pardo, MJ. Marti, Y. Compta, F. Valldeoriola, N. Bargallo, A. Iranzo, C. Junque, B. Segura (Barcelona, Spain)

  • « Previous Page
  • 1
  • …
  • 67
  • 68
  • 69
  • 70
  • 71
  • …
  • 153
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Month
  • All Time
  • #25179 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley